20 Stocks That Will Double in 2026
Solid BiosciencesSolid Biosciences(US:SLDB) Insider Monkey·2025-12-15 05:12

Market Outlook - Kevin Mahn of Hennion & Walsh discussed the potential for a bullish year in 2026, despite expected volatility, citing historical data that shows the S&P 500 has risen by an average of just under 14% following 23 Fed interest rate cuts when the index was within 2% of its all-time high since 1950 [1] - Mahn anticipates that if the Fed cuts interest rates, the target rate would fall to a range of 3.5% to 3.75%, with only 50 basis points remaining to reach the Fed's neutral rate of 3% [2] Company Analysis: Bitfarms Ltd. (NASDAQ:BITF) - Bitfarms is projected to have an average upside potential of 104.08% by 2026, with 25 hedge funds holding stakes in the company [7] - The company reported Q3 2025 revenue of $83.66 million, an 86.52% increase year-over-year, although it missed Street expectations by $998.78K, and incurred a quarterly loss of $0.15 per share [10] - Bitfarms is transitioning from Bitcoin mining to becoming a leading North American HPC and AI infrastructure provider, which involves significant capital expenditure and operational changes, leading to execution risks [9] Company Analysis: Solid Biosciences Inc. (NASDAQ:SLDB) - Solid Biosciences has an average upside potential of 155.10% by 2026, with 25 hedge funds holding stakes in the company [11] - The company ended Q3 2025 with $236.1 million in cash and equivalents, up from $148.9 million at the end of 2024, which is expected to fund operations into H1 2027 [12] - Solid Biosciences' SGT-003 gene therapy trial has shown strong efficacy, with plans to meet with the FDA in H1 2026 to discuss accelerated approval pathways [13]

Solid Biosciences-20 Stocks That Will Double in 2026 - Reportify